Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Music | 14 | 2024 | 42 | 5.310 |
Why?
|
| Cognition Disorders | 19 | 2019 | 46 | 3.370 |
Why?
|
| Dementia | 19 | 2024 | 77 | 3.270 |
Why?
|
| Cognitive Dysfunction | 12 | 2024 | 66 | 2.800 |
Why?
|
| Aged | 48 | 2024 | 859 | 2.320 |
Why?
|
| Alzheimer Disease | 15 | 2019 | 90 | 2.210 |
Why?
|
| Singing | 7 | 2024 | 18 | 2.020 |
Why?
|
| Humans | 73 | 2024 | 5476 | 1.780 |
Why?
|
| Aging | 10 | 2021 | 127 | 1.710 |
Why?
|
| Middle Aged | 39 | 2024 | 1098 | 1.670 |
Why?
|
| Neuropsychological Tests | 27 | 2018 | 176 | 1.650 |
Why?
|
| Brain | 12 | 2018 | 286 | 1.550 |
Why?
|
| Music Therapy | 6 | 2024 | 15 | 1.540 |
Why?
|
| Male | 49 | 2024 | 2765 | 1.520 |
Why?
|
| Female | 49 | 2024 | 2811 | 1.470 |
Why?
|
| Aged, 80 and over | 23 | 2024 | 320 | 1.300 |
Why?
|
| Aphasia | 4 | 2015 | 10 | 1.250 |
Why?
|
| Neurology | 4 | 2015 | 4 | 1.010 |
Why?
|
| Caregivers | 3 | 2024 | 42 | 0.960 |
Why?
|
| Loneliness | 3 | 2024 | 11 | 0.920 |
Why?
|
| Language | 5 | 2015 | 55 | 0.900 |
Why?
|
| Auditory Perceptual Disorders | 2 | 2015 | 2 | 0.880 |
Why?
|
| Quality of Life | 7 | 2021 | 117 | 0.880 |
Why?
|
| Cognition | 10 | 2024 | 174 | 0.840 |
Why?
|
| Neurodegenerative Diseases | 4 | 2010 | 13 | 0.790 |
Why?
|
| Independent Living | 2 | 2021 | 20 | 0.790 |
Why?
|
| Psychometrics | 6 | 2012 | 101 | 0.740 |
Why?
|
| Patient Selection | 2 | 2020 | 10 | 0.730 |
Why?
|
| Trust | 2 | 2020 | 10 | 0.730 |
Why?
|
| Awareness | 1 | 2021 | 6 | 0.700 |
Why?
|
| Attention | 3 | 2012 | 77 | 0.700 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 14 | 0.700 |
Why?
|
| Public Health | 1 | 2021 | 22 | 0.690 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2012 | 250 | 0.670 |
Why?
|
| Health Care Costs | 1 | 2020 | 11 | 0.660 |
Why?
|
| Dancing | 1 | 2020 | 27 | 0.650 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 20 | 0.650 |
Why?
|
| Uncertainty | 1 | 2019 | 10 | 0.620 |
Why?
|
| Stress, Psychological | 2 | 2019 | 88 | 0.590 |
Why?
|
| Heart Failure | 3 | 2012 | 32 | 0.560 |
Why?
|
| Memory | 6 | 2013 | 55 | 0.530 |
Why?
|
| History, 19th Century | 5 | 2015 | 8 | 0.480 |
Why?
|
| Health Promotion | 1 | 2015 | 39 | 0.480 |
Why?
|
| Psychology | 1 | 2015 | 4 | 0.470 |
Why?
|
| Hearing Disorders | 1 | 2015 | 1 | 0.470 |
Why?
|
| Executive Function | 7 | 2017 | 75 | 0.450 |
Why?
|
| Critical Illness | 2 | 2024 | 6 | 0.450 |
Why?
|
| Respiration, Artificial | 2 | 2024 | 6 | 0.450 |
Why?
|
| Activities of Daily Living | 3 | 2015 | 57 | 0.440 |
Why?
|
| United States | 7 | 2023 | 521 | 0.430 |
Why?
|
| Mobile Health Units | 2 | 2023 | 2 | 0.410 |
Why?
|
| Physicians | 1 | 2013 | 18 | 0.410 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 5 | 0.400 |
Why?
|
| Models, Statistical | 1 | 2012 | 70 | 0.390 |
Why?
|
| Problem Solving | 2 | 2009 | 14 | 0.390 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2011 | 2 | 0.360 |
Why?
|
| Auditory Perception | 1 | 2011 | 24 | 0.360 |
Why?
|
| Severity of Illness Index | 5 | 2012 | 71 | 0.350 |
Why?
|
| Geriatric Assessment | 4 | 2013 | 7 | 0.350 |
Why?
|
| Qualitative Research | 5 | 2024 | 47 | 0.340 |
Why?
|
| Focus Groups | 2 | 2020 | 16 | 0.340 |
Why?
|
| Concept Formation | 1 | 2010 | 11 | 0.330 |
Why?
|
| Surveys and Questionnaires | 7 | 2021 | 277 | 0.300 |
Why?
|
| Adult | 12 | 2024 | 1683 | 0.290 |
Why?
|
| Frontotemporal Dementia | 3 | 2015 | 5 | 0.290 |
Why?
|
| Pandemics | 3 | 2024 | 82 | 0.270 |
Why?
|
| Frontal Lobe | 2 | 2004 | 16 | 0.270 |
Why?
|
| Motor Activity | 1 | 2007 | 66 | 0.270 |
Why?
|
| Case-Control Studies | 5 | 2016 | 96 | 0.270 |
Why?
|
| Residence Characteristics | 3 | 2018 | 24 | 0.260 |
Why?
|
| Socioeconomic Factors | 3 | 2017 | 43 | 0.250 |
Why?
|
| Prospective Studies | 3 | 2012 | 132 | 0.250 |
Why?
|
| Emotions | 3 | 2018 | 83 | 0.240 |
Why?
|
| Demography | 1 | 2005 | 17 | 0.240 |
Why?
|
| Behavior | 3 | 2011 | 5 | 0.230 |
Why?
|
| Social Isolation | 1 | 2024 | 9 | 0.230 |
Why?
|
| Longitudinal Studies | 4 | 2014 | 148 | 0.230 |
Why?
|
| Critical Care | 1 | 2024 | 12 | 0.230 |
Why?
|
| Anthropology, Cultural | 1 | 2024 | 5 | 0.220 |
Why?
|
| Family | 1 | 2024 | 26 | 0.220 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2004 | 9 | 0.220 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2016 | 18 | 0.220 |
Why?
|
| Functional Laterality | 4 | 2009 | 38 | 0.220 |
Why?
|
| History, 20th Century | 2 | 2015 | 13 | 0.210 |
Why?
|
| Social Work | 2 | 2023 | 5 | 0.210 |
Why?
|
| Agnosia | 1 | 2003 | 2 | 0.200 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 28 | 0.200 |
Why?
|
| Factor Analysis, Statistical | 2 | 2013 | 41 | 0.200 |
Why?
|
| Vaccines | 1 | 2022 | 5 | 0.200 |
Why?
|
| Hypertension | 1 | 2023 | 61 | 0.200 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2022 | 2 | 0.190 |
Why?
|
| HIV Infections | 1 | 2024 | 115 | 0.190 |
Why?
|
| Atrophy | 3 | 2010 | 4 | 0.180 |
Why?
|
| Brain Mapping | 3 | 2011 | 78 | 0.180 |
Why?
|
| Ghana | 1 | 2021 | 1 | 0.180 |
Why?
|
| Religion | 1 | 2021 | 7 | 0.180 |
Why?
|
| Beneficence | 1 | 2020 | 1 | 0.180 |
Why?
|
| Health Education | 1 | 2021 | 20 | 0.180 |
Why?
|
| Social Media | 1 | 2021 | 8 | 0.170 |
Why?
|
| Communication | 1 | 2021 | 33 | 0.170 |
Why?
|
| Adaptation, Psychological | 1 | 2021 | 44 | 0.170 |
Why?
|
| Auditory Pathways | 2 | 2015 | 3 | 0.170 |
Why?
|
| Interpersonal Relations | 1 | 2020 | 58 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2020 | 119 | 0.160 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 284 | 0.160 |
Why?
|
| Euthanasia | 1 | 2019 | 1 | 0.160 |
Why?
|
| Bioethical Issues | 1 | 2019 | 2 | 0.160 |
Why?
|
| Research Subjects | 1 | 2019 | 2 | 0.160 |
Why?
|
| Research Personnel | 1 | 2019 | 5 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2009 | 115 | 0.160 |
Why?
|
| Ethics, Research | 1 | 2019 | 2 | 0.160 |
Why?
|
| Personal Autonomy | 1 | 2019 | 10 | 0.160 |
Why?
|
| Amnesia | 2 | 2010 | 2 | 0.150 |
Why?
|
| Prefrontal Cortex | 2 | 2009 | 39 | 0.150 |
Why?
|
| Psychomotor Performance | 4 | 2010 | 107 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2018 | 12 | 0.150 |
Why?
|
| Cohort Studies | 4 | 2021 | 131 | 0.150 |
Why?
|
| Education | 1 | 2018 | 2 | 0.150 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 3 | 0.150 |
Why?
|
| Germany | 2 | 2012 | 5 | 0.150 |
Why?
|
| Minority Groups | 1 | 2018 | 39 | 0.140 |
Why?
|
| Single Person | 1 | 2018 | 1 | 0.140 |
Why?
|
| Transgender Persons | 1 | 2018 | 1 | 0.140 |
Why?
|
| Homosexuality | 1 | 2018 | 3 | 0.140 |
Why?
|
| Bisexuality | 1 | 2018 | 5 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2017 | 15 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 52 | 0.130 |
Why?
|
| Alcoholism | 1 | 2017 | 43 | 0.130 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 10 | 0.130 |
Why?
|
| Climate | 1 | 2016 | 1 | 0.130 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2016 | 1 | 0.130 |
Why?
|
| Air Conditioning | 1 | 2016 | 2 | 0.130 |
Why?
|
| Air Pollution, Indoor | 1 | 2016 | 2 | 0.130 |
Why?
|
| Humidity | 1 | 2016 | 3 | 0.120 |
Why?
|
| Mental Status Schedule | 3 | 2013 | 3 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 97 | 0.120 |
Why?
|
| Housing | 1 | 2016 | 11 | 0.120 |
Why?
|
| Mood Disorders | 1 | 2016 | 6 | 0.120 |
Why?
|
| Research Design | 1 | 2015 | 35 | 0.120 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 20 | 0.120 |
Why?
|
| Apolipoprotein E4 | 3 | 2014 | 5 | 0.120 |
Why?
|
| Guidelines as Topic | 2 | 2014 | 4 | 0.120 |
Why?
|
| Medical Illustration | 1 | 2015 | 1 | 0.120 |
Why?
|
| History, 18th Century | 1 | 2015 | 1 | 0.120 |
Why?
|
| History, 17th Century | 1 | 2015 | 2 | 0.120 |
Why?
|
| Analysis of Variance | 2 | 2016 | 81 | 0.110 |
Why?
|
| San Francisco | 2 | 2024 | 5 | 0.110 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2014 | 1 | 0.110 |
Why?
|
| Life Change Events | 1 | 2014 | 18 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 32 | 0.110 |
Why?
|
| Algorithms | 2 | 2012 | 276 | 0.100 |
Why?
|
| Finland | 1 | 2013 | 1 | 0.100 |
Why?
|
| World Health Organization | 1 | 2013 | 1 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2013 | 30 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2013 | 31 | 0.100 |
Why?
|
| Social Environment | 1 | 2013 | 15 | 0.100 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2013 | 21 | 0.100 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 27 | 0.100 |
Why?
|
| Supranuclear Palsy, Progressive | 2 | 2010 | 2 | 0.100 |
Why?
|
| Nerve Net | 1 | 2013 | 46 | 0.100 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 19 | 0.100 |
Why?
|
| Statistics, Nonparametric | 2 | 2010 | 7 | 0.100 |
Why?
|
| Neurotic Disorders | 1 | 2012 | 1 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2012 | 188 | 0.090 |
Why?
|
| Depression | 1 | 2013 | 133 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2014 | 350 | 0.090 |
Why?
|
| Sex Factors | 2 | 2009 | 81 | 0.090 |
Why?
|
| Organ Size | 1 | 2010 | 31 | 0.090 |
Why?
|
| Disease Progression | 1 | 2010 | 74 | 0.080 |
Why?
|
| Tool Use Behavior | 1 | 2010 | 1 | 0.080 |
Why?
|
| Sound | 1 | 2010 | 5 | 0.080 |
Why?
|
| Reference Values | 1 | 2010 | 28 | 0.080 |
Why?
|
| Acoustic Stimulation | 1 | 2010 | 21 | 0.080 |
Why?
|
| Motor Cortex | 1 | 2010 | 22 | 0.080 |
Why?
|
| Semantics | 3 | 2005 | 26 | 0.080 |
Why?
|
| Time Factors | 2 | 2007 | 176 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 8 | 0.080 |
Why?
|
| Ocular Motility Disorders | 1 | 2008 | 3 | 0.070 |
Why?
|
| Inclusion Bodies | 2 | 2006 | 3 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2022 | 29 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 30 | 0.070 |
Why?
|
| tau Proteins | 2 | 2005 | 9 | 0.070 |
Why?
|
| Health Status | 1 | 2007 | 30 | 0.070 |
Why?
|
| Child | 2 | 2022 | 657 | 0.070 |
Why?
|
| Cerebellar Ataxia | 1 | 2006 | 1 | 0.060 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2006 | 1 | 0.060 |
Why?
|
| Glutamate Decarboxylase | 1 | 2006 | 2 | 0.060 |
Why?
|
| Diagnosis, Differential | 4 | 2008 | 18 | 0.060 |
Why?
|
| Antibodies | 1 | 2006 | 28 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 14 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 20 | 0.060 |
Why?
|
| Parkinsonian Disorders | 1 | 2005 | 3 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2005 | 49 | 0.060 |
Why?
|
| Down Syndrome | 1 | 2005 | 16 | 0.060 |
Why?
|
| Social Stigma | 1 | 2024 | 6 | 0.060 |
Why?
|
| Self-Management | 1 | 2024 | 3 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2024 | 17 | 0.060 |
Why?
|
| Speech | 2 | 2021 | 17 | 0.060 |
Why?
|
| Delirium | 1 | 2024 | 7 | 0.060 |
Why?
|
| Learning | 1 | 2005 | 50 | 0.060 |
Why?
|
| Aphasia, Broca | 1 | 2004 | 1 | 0.060 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2004 | 5 | 0.050 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2004 | 7 | 0.050 |
Why?
|
| Neurofibrillary Tangles | 1 | 2004 | 1 | 0.050 |
Why?
|
| Cadaver | 1 | 2004 | 3 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2004 | 5 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2004 | 8 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 19 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 5 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 10 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2003 | 19 | 0.050 |
Why?
|
| Social Workers | 1 | 2023 | 3 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 35 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2023 | 22 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 22 | 0.050 |
Why?
|
| Neurophysiology | 1 | 2003 | 1 | 0.050 |
Why?
|
| Intention | 1 | 2022 | 19 | 0.050 |
Why?
|
| Age Factors | 2 | 2018 | 75 | 0.050 |
Why?
|
| Policy | 1 | 2022 | 4 | 0.050 |
Why?
|
| Anxiety | 1 | 2024 | 173 | 0.050 |
Why?
|
| Risk Factors | 2 | 2018 | 184 | 0.050 |
Why?
|
| Adult Children | 1 | 2021 | 3 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 136 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2023 | 382 | 0.050 |
Why?
|
| Memory, Short-Term | 2 | 2016 | 49 | 0.040 |
Why?
|
| Motivation | 1 | 2020 | 70 | 0.040 |
Why?
|
| Switzerland | 1 | 2019 | 1 | 0.040 |
Why?
|
| Mandatory Reporting | 1 | 2019 | 1 | 0.040 |
Why?
|
| Mental Health | 1 | 2020 | 58 | 0.040 |
Why?
|
| Decision Making | 1 | 2019 | 12 | 0.040 |
Why?
|
| Reaction Time | 2 | 2013 | 60 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2018 | 11 | 0.040 |
Why?
|
| District of Columbia | 1 | 2018 | 3 | 0.040 |
Why?
|
| Health Services | 1 | 2018 | 8 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2018 | 24 | 0.040 |
Why?
|
| Logistic Models | 1 | 2018 | 69 | 0.030 |
Why?
|
| Trail Making Test | 1 | 2017 | 1 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 72 | 0.030 |
Why?
|
| Mortality | 1 | 2017 | 3 | 0.030 |
Why?
|
| Utah | 1 | 2016 | 1 | 0.030 |
Why?
|
| Pyroglyphidae | 1 | 2016 | 2 | 0.030 |
Why?
|
| Dust | 1 | 2016 | 2 | 0.030 |
Why?
|
| Seasons | 1 | 2016 | 11 | 0.030 |
Why?
|
| Orientation | 1 | 2016 | 26 | 0.030 |
Why?
|
| Pedigree | 2 | 2005 | 7 | 0.030 |
Why?
|
| Literacy | 1 | 2014 | 2 | 0.030 |
Why?
|
| Space Perception | 2 | 2005 | 21 | 0.030 |
Why?
|
| Individuality | 1 | 2014 | 16 | 0.030 |
Why?
|
| Educational Status | 1 | 2014 | 30 | 0.030 |
Why?
|
| Genotype | 1 | 2014 | 58 | 0.030 |
Why?
|
| Social Class | 1 | 2014 | 22 | 0.030 |
Why?
|
| Memory, Episodic | 1 | 2014 | 38 | 0.030 |
Why?
|
| Indans | 1 | 2013 | 9 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2013 | 34 | 0.030 |
Why?
|
| Piperidines | 1 | 2013 | 17 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2013 | 148 | 0.020 |
Why?
|
| Disease Management | 1 | 2011 | 6 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 9 | 0.020 |
Why?
|
| Self Report | 1 | 2012 | 72 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 18 | 0.020 |
Why?
|
| ROC Curve | 1 | 2011 | 31 | 0.020 |
Why?
|
| Animals | 1 | 2016 | 1817 | 0.020 |
Why?
|
| Eye Movement Measurements | 1 | 2008 | 7 | 0.020 |
Why?
|
| Pursuit, Smooth | 1 | 2008 | 17 | 0.020 |
Why?
|
| Language Disorders | 1 | 2008 | 7 | 0.020 |
Why?
|
| Saccades | 1 | 2008 | 17 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2008 | 37 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2008 | 40 | 0.020 |
Why?
|
| Thiazoles | 1 | 2006 | 4 | 0.020 |
Why?
|
| Benzothiazoles | 1 | 2006 | 3 | 0.020 |
Why?
|
| Age of Onset | 1 | 2006 | 3 | 0.020 |
Why?
|
| Tauopathies | 1 | 2006 | 5 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2006 | 8 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2006 | 1 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2005 | 2 | 0.020 |
Why?
|
| Presenilin-1 | 1 | 2005 | 2 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 8 | 0.020 |
Why?
|
| Intelligence | 1 | 2005 | 29 | 0.010 |
Why?
|
| Anatomy | 1 | 2004 | 1 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2004 | 1 | 0.010 |
Why?
|
| Lod Score | 1 | 2004 | 1 | 0.010 |
Why?
|
| Synucleins | 1 | 2004 | 1 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2004 | 3 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2004 | 5 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 6 | 0.010 |
Why?
|
| alpha-Synuclein | 1 | 2004 | 4 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 16 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 19 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2004 | 19 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2004 | 5 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 38 | 0.010 |
Why?
|
| Psychomotor Disorders | 1 | 2003 | 2 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 137 | 0.010 |
Why?
|